HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur

Abstract : The purpose of this review of the literature is to document how breast cancer patients perceive the use of tumor gene profiling approaches to better adapt treatments, and to identify the features of these approaches that may impact their clinical application. In general, the use of tumor genomic analysis was perceived by patients as an approach facilitating personalized medicine and received considerable support. Nevertheless, a number of confusions and worries about these practices were also identified. Improving the quality of provider/patient communications should enable patients to play a more active part in the decision-making about their treatment. This will ensure that those who agree to their tumor gene analysis have realistic expectations and sound deductions of the final result disclosure process.
Document type :
Journal articles
Complete list of metadata

Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 7:26:32 PM
Last modification on : Saturday, April 2, 2022 - 3:28:59 AM

Links full text




Isabelle Pellegrini, Myrto Rapti, Jean-Marc Extra, Anouk Petri-Cal, Themis Apostolidis, et al.. Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur. médecine/sciences, EDP Sciences, 2012, 28, pp.24-27. ⟨10.1051/medsci/2012281s107⟩. ⟨hal-03623782⟩



Record views